Equifax/$EFX
1D1W1MYTD1Y5YMAX
Capital at risk
About Equifax
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, about 40% of the firm's revenue comes from Workforce Solutions, which provides income verification and employer human resources services. Equifax generates about 25% of its revenue from outside the United States.
- Ticker
- $EFX
- Sector
- Business services
- Primary listing
- NYSE
- Employees
- 15,000
- Headquarters
- Atlanta, United States
- Website
- www.equifax.com
Equifax Metrics
BasicAdvanced
$20B
30.28
$5.69
1.32
$1.62
1.30%
Price and volume
Market cap
$20B
Beta
1.32
52-week high
$271.84
52-week low
$150.75
Average daily volume
1.1M
Dividend rate
$1.62
Financial strength
Current ratio
0.602
Quick ratio
0.485
Long term debt to equity
0.898
Total debt to equity
1.21
Dividend payout ratio (TTM)
37.00%
Interest coverage (TTM)
5.31%
Profitability
EBITDA (TTM)
1,924.4
Gross margin (TTM)
55.54%
Net profit margin (TTM)
10.73%
Operating margin (TTM)
18.26%
Effective tax rate (TTM)
26.00%
Revenue per employee (TTM)
$430,000
Management effectiveness
Return on assets (TTM)
6.16%
Return on equity (TTM)
14.27%
Valuation
Price to earnings (TTM)
30.283
Price to revenue (TTM)
3.228
Price to book
4.63
Price to tangible book (TTM)
-5.43
Price to free cash flow (TTM)
18.827
Free cash flow yield (TTM)
5.31%
Free cash flow per share (TTM)
9.151
Dividend yield (TTM)
0.94%
Forward dividend yield
1.30%
Growth
Revenue change (TTM)
10.35%
Earnings per share change (TTM)
11.13%
3-year revenue growth (CAGR)
8.38%
10-year revenue growth (CAGR)
8.41%
3-year earnings per share growth (CAGR)
10.14%
10-year earnings per share growth (CAGR)
4.01%
3-year dividend per share growth (CAGR)
10.77%
10-year dividend per share growth (CAGR)
5.51%
What the Analysts think about Equifax
Analyst ratings (Buy, Hold, Sell) for Equifax stock.
Analyst projections of the future price of Equifax stock.
Bulls say / Bears say
Strong Q2 2026 revenue growth of 11% year-over-year to $1.70 billion (10% in local currency), underpinned by a 16% new product Vitality Index and double-digit growth across Workforce Solutions and USIS, reflecting resilient, innovation-led performance. (Equifax IR)
Signed a definitive agreement to acquire Mexico’s fastest-growing credit bureau Círculo de Crédito for $750 million, expanding Equifax’s footprint in the high-growth Latin American market and enhancing its international revenue mix. (Equifax IR)
Doubled its 2026–28 AI-driven cost reduction target to $150 million, demonstrating commitment to leveraging AI for operational efficiency and potential margin improvement. (Equifax IR)
Full-year 2026 revenue guidance of $6.71 billion to $6.78 billion is modestly below the $6.76 billion analyst consensus, signaling potential top-line pressure in the mortgage-impacted market. (Reuters)
Net income attributable to Equifax declined 4% year-over-year to $183.9 million in Q2 2026 despite revenue growth, indicating margin compression and rising costs. (Equifax IR)
Recorded a $40 million net charge (after insurance proceeds) in Q2 2026 for a legal settlement related to a coding issue, highlighting ongoing litigation risks and potential for further liabilities. (Equifax 8-K)
Data summarised monthly by Lightyear AI. Last updated on 4 Sept 2026.
Equifax Financial Performance
Revenues and expenses
Equifax Earnings Performance
Company profitability
Upcoming events
No upcoming events
Equifax News
AllArticlesVideos
Funds containing Equifax
AllEURGBPUSD
Fund name | Fund size | $EFX weighting |
|---|---|---|
VanEck Morningstar Wide Moat€GMVM | €407M | 1.04% |
VanEck Morningstar Wide Moat£MOGB | £354M | 1.04% |
iShares S&P 500 Industrials Sector€2B7C | €673M | 0.39% |
iShares S&P 500 Industrials Sector£IISU | £578M | 0.39% |
iShares S&P 500 Equal Weight£EWSP | £3.7B | 0.21% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.